Article
Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering.
Scientific reports - 14 Jan 2014
Thakkar Shraddha, Nanaware-Kharade Nisha, Celikel Reha, Peterson Eric C, Varughese Kottayil I
Abstract excerpt
Methamphetamine (METH) abuse is a worldwide threat, without any FDA approved medications. Anti-METH IgGs and single chain fragments (scFvs) have shown efficacy in preclinical studies. Here we report affinity enhancement of an anti-METH scFv for METH and its active metabolite amphetamine (AMP), through the introduction of point mutations, rationally designed to optimize the shape and hydrophobicity of the antibody...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
